DarioHealth

Catch DarioHealth Chief Medical Officer, Omar Manejwala, M.D. and Floreo Chief Medical Officer Benjamin A. tomorrow at 10:00 am CDT discussing recent trends in mental health mergers and acquisitions. This meeting will dive deep into the strategic alliances, partnerships, and acquisitions reshaping the delivery of mental health services in the digital age. https://hubs.li/Q02KZNh60

We're excited to share today the reported financial results for the second quarter 2024. In the second quarter, we drove significant growth in our core business-to-business-to-consumer (B2B2C) channel. Our B2B2C channel grew 60% sequentially over the first quarter of 2024, and 315% over the second quarter of 2023, primarily due to Aetna customer sign on, expansions of existing customer contracts, new customer launches, and the addition of Twill, Inc. ("Twill") revenues following our acquisition of Twill in the first quarter of 2024. The organic sequential growth of this channel is 28%. Our legacy direct to consumer (B2C) business remains at its consistent run rate at $7.6 million. The link to the press release and research results can be found in the comments below.

*Reminder: DarioHealth to Report Second Quarter 2024 Results on Thursday, August 8th We will be releasing the financial results for the 2nd quarter that ended on June 30th, 2024, on Thursday, August 8th, 2024, before the market opens and will host a conference call and webcast at 8:30 am Eastern Time. Erez Raphael, Chief Executive Officer, and Steven Nelson, Chief Commercial Officer, will host the call.

Check out our Chief Medical Officer, Omar Manejwala, M.D. talk about how DarioHealth helps employers support employees with chronic conditions, the advancement of the platform after the Twill acquisition, and expansion of reach with Medicaid. #Dario #digitalhealth

In this edition of Dario Digital Digest, we delve into how we support our members in achieving diabetes remission. Our Cardiometabolic Solution equips members with the tools needed for effective weight loss, increased physical activity, and proper diet management. #Dario #DigitalHealth #DiabetesRemission

Proud to be recognized as a leader in the digital health market as one of the world's best digital health companies in 2024. #Dario #Dariohealth #digitalhealth

We are excited to share our latest findings and insights on helping members achieve diabetes remission. Our comprehensive approach is designed to support members on their journey to better health outcomes. Read more in our latest executive brief - link is available in the comments. #digitalhealth #dario

We're excited to share a new contract with a national employer to provide its cardiometabolic solution with integrated support for GLP-1s to employees beginning in the third quarter of 2024. The employer, a leader in environmental services, selected Dario’s cardiometabolic suite to address multiple health conditions, including diabetes, pre-diabetes, hypertension and weight management needs, including integrated support for those employees taking a GLP-1 medication. Dario’s proven ability to drive sustainable behavior change is key to helping employees achieve successful outcomes while taking a GLP-1, as research shows that 68% of people stop taking these medications within a year, putting them at high-risk of regaining the weight lost. The link to the press release and research results can be found in the comments below.

Happy 4th of July 🇺🇸

In the upcoming edition of the Dario Digital Digest, we highlight our latest study presented at the 84th Annual American Diabetes Association (ADA) Scientific Sessions. This new research demonstrates the significant value of using our digital health solution, designed to foster behavior change alongside GLP-1 medications. #ADA #clinicalresearch #digitalhealth #GLP1s